Author

Yeonhee Kim

Observed name: Kim, Yeonhee

Institution: Lyell Immunopharma (United States)

Observed institutions: Bristol-Myers Squibb (United States), Lyell Immunopharma (United States)

ORCID: 0000-0002-3209-916X

Observed ORCID: 0000-0002-3209-916X

OpenAlex ID: A5023208214

Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al. · Molecular Cancer Therapeutics · 16

Real-world data and evidence in the development of cell and gene therapies

2026 · Yeonhee Kim, Shihua Wen, et al. · Journal of Biopharmaceutical Statistics

Supplementary Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Supplementary Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Data from Exploration of Tumor Biopsy Gene Signatures to Understand the Role of the Tumor Microenvironment in Outcomes to Lisocabtagene Maraleucel

2023 · N. Eric Olson, Seamus P. Ragan, et al.

Works count: 9

Citation count: 16

H-index: 1

I10-index: 1